Search Results - "YAMADE, M"

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype by Kagami, T., Sahara, S., Ichikawa, H., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K., Miyajima, H., Furuta, T.

“…Summary Background Acid inhibitory effects of proton pump inhibitors (PPIs) are influenced by CYP2C19 genotype. In contrast, the potent acid inhibition of…”
Get full text

High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication by Furuta, T., Baba, S., Yamade, M., Uotani, T., Kagami, T., Suzuki, T., Tani, S., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K.

“…Summary Background Although autoimmune gastritis (AIG) is generally considered relatively rare, we frequently encounter AIG among patients at to our hospital…”
Get full text

Pharmacogenomics‐based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori by Furuta, T, Shirai, N, Kodaira, M, Sugimoto, M, Nogaki, A, Kuriyama, S, Iwaizumi, M, Yamade, M, Terakawa, I, Ohashi, K, Ishizaki, T, Hishida, A

“…Helicobacter pylori eradication rates by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin at standard doses depend on bacterial…”
Get full text

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype by Sugimoto, M., Shirai, N., Nishino, M., Kodaira, C., Uotani, T., Yamade, M., Sahara, S., Ichikawa, H., Sugimoto, K., Miyajima, H., Furuta, T.

“…Summary Background Standard dosing (i.e. once daily) of proton pump inhibitors (PPIs) cannot inhibit acid secretion for a full 24 h. Better therapeutic…”
Get full text

Twice‐daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice‐daily omeprazole, rabeprazole or lansoprazole by Sahara, S., Sugimoto, M., Uotani, T., Ichikawa, H., Yamade, M., Iwaizumi, M., Yamada, T., Osawa, S., Sugimoto, K., Umemura, K., Miyajima, H., Furuta, T.

“…Summary Background Twice‐daily dosing of proton pump inhibitors (PPIs) is used to treat Helicobacter pylori or acid‐related diseases, such as…”
Get full text

252 The DNA damage response gene Schlafen 11 (SLFN11) is a transcriptional target of ETS transcription factors in Ewing's sarcoma and other cancers by Pommier, Y, Bilke, S.W, Sousa, F, Yamade, M, Murai, J, Rajapakse, V, Helman, L, Meltzer, P

Get full text

[13C]‐pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole by FURUTA, T., KODAIRA, C., NISHINO, M., YAMADE, M., SUGIMOTO, M., IKUMA, M., HISHIDA, A., WATANABE, H., UMEMURA, K.

“…Summary Background  13CO2 is produced on metabolism of 13C‐labelled‐pantoprazole ([13C]‐pantoprazole) by CYP2C19. Aim  To investigate whether the…”
Get full text

Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP2C19 genotypes and 23s rRNA genotypes of H. pylori by FURUTA, T, SUGIMOTO, M, IKUMA, M, WATANABE, H, UMEMURA, K, ISHIZAKI, T, HISHIDA, A, SHIRAI, N, MATSUSHITA, F, NAKAJIMA, H, KUMAGAI, J, SENOO, K, KODAIRA, C, NISHINO, M, YAMADE, M

Get full text

Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori by FURUTA, T., SUGIMOTO, M., SHIRAI, N., MATSUSHITA, F., NAKAJIMA, H., KUMAGAI, J., SENOO, K., KODAIRA, C., NISHINO, M., YAMADE, M., IKUMA, M., WATANABE, H., UMEMURA, K., ISHIZAKI, T., HISHIDA, A.

“…Summary Background Polymorphism in MDR1 is associated with variation in the plasma level of a proton pump inhibitor. Aim To investigate whether MDR1…”
Get full text

Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype by Kagami, Takuma, Yamade, Mihoko, Suzuki, Takahiro, Uotani, Takahiro, Hamaya, Yasushi, Iwaizumi, Moriya, Osawa, Satoshi, Sugimoto, Ken, Umemura, Kazuo, Miyajima, Hiroaki, Furuta, Takahisa

“…Drug–drug interaction between antiacid and antiplatelet agents has not been fully elucidated. Vonoprazan, a new potassium competitive acid blocker, has been…”
Get full text

Characterization and electrode behavior of LixCoO2(x>1) by Imanishi, N., Yamade, M., Ichikawa, T., Hirano, A., Takeda, Y.

Get full text

Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP 2C19 genotype by Kagami, T., Sahara, S., Ichikawa, H., Uotani, T., Yamade, M., Sugimoto, M., Hamaya, Y., Iwaizumi, M., Osawa, S., Sugimoto, K., Miyajima, H., Furuta, T.

Get full text

Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel by Furuta, Takahisa, Sugimoto, Mitsushige, Kodaira, Chise, Nishino, Masafumi, Yamade, Mihoko, Uotani, Takahiro, Sahara, Shu, Ichikawa, Hitomi, Kagami, Takuma, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Sugimoto, Ken, Umemura, Kazuo

“…Proton pump inhibitors (PPIs) at low doses can effectively prevent gastrointestinal bleeding due to aspirin and are widely used in Japan for gastroprotection…”
Get full text

Rabeprazole 10 mg q.d.s. decreases 24‐h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP 2 C 19 genotype by Sugimoto, M., Shirai, N., Nishino, M., Kodaira, C., Uotani, T., Yamade, M., Sahara, S., Ichikawa, H., Sugimoto, K., Miyajima, H., Furuta, T.

Get full text

Trastuzumab Has Opposing Effects on SN-38-induced Double-strand Breaks and Cytotoxicity in HER2-positive Gastric Cancer Cells Depending on Administration Sequence by YAMADE, Mihoko, SUGIMOTO, Mitsushige, FURUTA, Takahisa, NISHINO, Masafumi, UOTANI, Takahiro, SAHARA, Shu, IWAIZUMI, Moriya, YAMADA, Takanori, OSAWA, Satoshi, SUGIMOTO, Ken, MIYAJIMA, Hiroaki

“…We investigated the effects of trastuzumab, an anti-HER2 humanized monoclonal antibody, on DNA breaks induced by SN-38, a topoisomerase-1 inhibitor, in gastric…”
Get full text

In-Water Dehydrative Alkylation of Ammonia and Amines with Alcohols by a Polymeric Bimetallic Catalyst by Ohta, Hidetoshi, Yuyama, Yoshinari, Uozumi, Yasuhiro, Yamada, Yoichi M. A

“…An in-water dehydrative alkylation with a novel heterobimetallic polymeric catalyst is described. Thus, a boron–iridium heterobimetallic polymeric catalyst was…”
Get full text

What is related to postoperative outcome of frail status in elective colorectal cancer surgery? by Tamura, Koichi, Matsuda, Kenji, Fujita, Yoichi, Sakaguchi, Satoru, Kinoshita, Hiroyuki, Yamade, Naohisa, Hotta, Tsukasa, Iwamoto, Hiromitsu, Mizumoto, Yuki, Yamaue, Hiroki

“…The population affected by colorectal cancer is growing, and there is an increasing need for prevention of functional decline following treatment. We proposed…”
Get full text

Isolation of temperature-sensitive cell cycle mutants from mouse FM3A cells. Characterization of mutants with special reference to DNA replication by EKI, T, ENOMOTO, T, MIYAJIMA, A, MIYAZAWA, H, MURAKAMI, Y, HANAOKA, F, YAMADA, M, UI, M

“…A large number of mutants that are temperature sensitive (ts) for growth have been isolated from mouse mammary carcinoma FM3A cells by an improved selection…”
Get full text